Amelie Lusque

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

Journal: Breast (Edinburgh, Scotland)

Published: March 19, 2026

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2026

Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective study.

Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective study.

Journal: The oncologist

Published: December 16, 2025

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer.

BRCA1/2, PALB2 mutations and first-line CDK4/6 inhibitor efficacy in HR+ metastatic breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: August 20, 2025

Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial.

Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 24, 2025

A comparison of CDKN2A status in gliomas using different techniques: The loss of p16 as a surrogate marker.

A comparison of CDKN2A status in gliomas using different techniques: The loss of p16 as a surrogate marker.

Journal: Journal of neuropathology and experimental neurology

Published: May 30, 2025

Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.

Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvement.

Journal: ESMO open

Published: January 29, 2025

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Durable Responses With Front-Line Rituximab in Autoimmune Cytopenias Associated With Indolent B-Cell Clones.

Journal: American journal of hematology

Published: October 15, 2024

Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis.

Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis.

Journal: The British journal of radiology

Published: September 23, 2024

TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study.

TNF signature in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study.

Journal: International journal of cancer

Published: September 19, 2024

Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities.

Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities.

Journal: Clinical and translational radiation oncology

Published: May 25, 2024

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.

Journal: ESMO open

Published: January 10, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026